Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology > Drugs for Neurodegenerative Diseases > Flashcards

Drugs for Neurodegenerative Diseases Flashcards

1
Q

Drugs that increase Dopamine levels

A 
Levodopa
Carbidopa
Amantadine
Selegiline
Rasagiline
Tolcapone
Entacapone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Levodopa - MoA

A

Increase dopamine levels by increasing the synthesis.

It is converted to dopamine by LAAD and metabolized to 3OMD by COMT. A drug that inhibits LAAD or COMT increases the amount of levodopa that enters brain tissue.

In the brain levodopa is taken up by dopaminergic neurons in the striatum and converted to dopamine by LAAD. Levodopa thereby increases the amount of dopamine released by the neurons in patients with PD, and is serves as a form of replacement thrapy. As the diseases progresses and more dopaminergic neurons are lost, the conversion of levodopa to dopamine therefor declines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Levodopa - Indication

A

Idiopathic PD
Postencephalitic parkinsonism

Parkisonian symptoms caused by carbon monoxide poisoning, manganese intoxication, or cerebral arteriosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Levodopa - Adverse effects

A

Nausea and vomiting (when used alone)
Orthostatic hypotension
Cardias dysrhythmias. Adverse effects are reduced with the use of Carbidopa.

Long term; involuntary movements or dyskinesias
Psychotic effects, including hallucination and disoriented thinking
Sedation, agitation, delirium, vivid dreams or nightmares, euphoria after drug adm.

Discoloration of urine, sweat and or saliva
Loss of appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Levodopa - Interactions

A

Anticholinergic drugs –> slow levodopa absorption

Nonselective MOAIs inhibit the breakdown of dopamine and sometimes cause hypertensive crisis in patients receiving levodopa

Antipsychotic drugs block dopamine receptors and can reduce the effectiveness of levodopa and exacerbate motor dysfunction

Drugs that promote gastric emptying (antacids) can increase levodopa bioavailibility

Ingestion of high-protein foods can decrease the effectiveness of levodopa because amino acids can reduce the transport of levodopa into the brain

LAAD requires Vitamin B6 (pyridoxine) as a cofactor. For this reason, vitamin B6 supplements may enhance the peripheral decarboxylation of levodopa and shoult not be coadministered with levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Carbidopa - Group + MoA

A

Analoug of levodopa

Inhibits LAAD thereby reducing the conversion of levodopa to dopamine in peripheral tissues and so increases the amount of levodopa that enters the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Carbidopa - Indication + Adverse effects

A

PD

Reduces the cardiovascular and GI side effects of Levodopa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amantadine - Group + MoA

A

Antiviral drug

Increases dopamine release from nigrostriatal neurons, may also inhibit the reuptake of dopamine by these neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amantadine - Indication

A

Early or mild cases of Parkinson disease

Prevention and treatment of influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amantadine - Adverse effects

A 
Sedation
Restlessness
Vivid dreams
Nausea
Dry mouth
Hypotension
Livedo reticularis- reddish-blue mottling of the skin with edema
CNS side effects are more common in elderly pat.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Selegiline - Group + MoA

A

Modified phenylethylamine compound

Increase dopamine by inhibiting the breakdown.

Inhibits Monoamine oxidase type B (MAO-B) and thereby prevents the oxidation of dopamine to dihydroxyphenylacetic acid and hydrogen peroxide. By this selegiline increases dopamine levels in the basal ganglia and decreases the formation of hydrogen peroxide. In the presence of iron, hydrogen peroxide is converted to hydroxyl and hydroxide free radicals that may participate in the degeneration of nigrostriatal neurons in patients with PD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Selegiline - Indication

A

Early or mild PD
Adjunct with levodopa for advanced disease, reduces the dose of levodopa needed, and may improve motor function in patients who experience wearing-off and on-off difficulties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selegiline + Rasagiline - Adverse effects

A 
Confusion
Dyskinesia
Hallucinations
Hypotension
Insomnia
Nausea.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Selegiline + Rasagiline - Interactions

A

Severe reactions may result if taken with meperidine or with fluoxetine or other SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rasagiline - MoA

A

MAO-B inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rasagiline - Indication

A

Monotherapy or adjunct medication in the treatment of parkinsonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tolcapone and Entacapone - MoA

A

Enhances the effectiveness of levopoa by inhibiting COMT, the enzyme that metabolize levodopa to 3OMD. By this action, it produces twofold increase in the oral bioavailability and half-life of levodopa.

Tolcapone: inhibits COMT in glial cells and inhibits conversion of dopamine to 3-methoxytyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tolcapone and Entacapone - Indication

A

PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tolcapone and Entacapone - Adverse effects

A 
Both:
Diarrhea
Nausea
Discoloration of urine, sweat, saliva
Tolcapone:
Rare: fatal hepatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Dopamine receptor agonists

A 
Bromocriptine
Pramipexole
Ropinirole
Rotigotine
Apomorphine
Benztropine
Trihexyphenidyl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dopamine receptor agonists - MoA

A

Directly activate dopamine receptors in the stratum. Because they do not require functional dopaminergic neuron to produce their effects, they are sometimes helpful in advanced cases of PD, in which few dopaminergic neurons remain. They work by primarily activating D2 receptors and this leads to inhibition of the indirect neuronal pathway from the striatum to the thalamus and increase thalamic stimulation of the motor area of the cortex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Dopamine receptor agonists - Adverse effects

A

Nausea
Orthostatic hypotension
Mental disturbances
Daytime sleepiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Bromocriptine - MoA

A

Is a D2 agonist and a D1 antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Bromocriptine - Indication

A

Adjunct to levodopa in patients who have advanced PD and experience wearing off effects and on-off motor fluctuations.
Diabetes type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Bromocriptine - Adverse effects
``` Decreased prolactin levels Pulmonary and cardiac fibrosis Orthostatic hypotension Dry mouth Nausea Dose-related CNS effects: confusion, dyskinesias, sedation, vivid dreams and hallucinations ```
26
Pramipexole and Rotigotine - MoA
Selective D2 agonists Also activates D3
27
Pramipexole - Indication
PD Delay the need of levodopa Restless leg syndrome
28
Pramipexole and Ropinirole - Adverse effects
``` Dizziness Hallucinations Insomnia Nausea Vomiting Sedation ```
29
Pramipexole - Interaction
Cimetidine inhibits renal excretion and increases serum levels
30
Ropinirole - MoA
Selective D2 agonists
31
Ropinirole and Rotigotine - Indication
PD | Restless leg syndrome
32
Ropinirole - Interaction
Ciprofloxacin increases serum levels
33
Rotigotine - Adverse effects
Somnolence Slight hypertension and tachycardia Site irritation
34
Apomorphine - MoA
Does not bind to opioid receptors, but rather Dopamine agonist.
35
Apomorphine - Indication
Treatment of acute intermittent hypomobility (freezing) episodes associated with PD
36
Benztropine and Trihexyphenidyl - MoA
Antagonists at cholinergic muscarinic receptor and also exhibit antihistamine activity Benztropine: may also inhibit the neuronal reuptake of dopamine and thereby prolong the action of dopamine
37
Benztropine and Trihexyphenidyl - Indication
May be helpful as adjunct therapy in combination with levodopa and other drugs that augment dopaminergic activity. They reduce tremor Can also reduce parkinsonian symptoms caused by dopamine receptor antagonists, such as haloperidol
38
Benztropine and Trihexyphenidyl - Adverse effects
``` Agitation Confusion Constipation Delirium Dry mouth Memory loss Urinary retention Tachycardia ```
39
Benztropine and Trihexyphenidyl - Interactions
Additive anticholinergic effects with antihistamines and phenothiazines
40
Drugs for Alzheimer disease
``` Donepezil Rivastigmine Tacrine Galantamine Memantine Caprylidene Dextrometorphan Quinidine ```
41
Donepezil, Rivastigmine, Tacrine and Galantamine - MoA
Reversible acetylcholinesterase inhibitors. | Donepezil and Rivastigmine: improves cholinergic neurotransmission
42
Donepezil - Adverse effects and Interactions
Bradycardia, diarrhea, GI bleeding, nausea, vomiting Anticholinergic drugs inhibit effects
43
Rivastigmine and Galantamine - Indication
Delays global cognitive impairment and slows the progression of AD.
44
Rivastigmine and Galantamine - Advese effects
Risk of bradycardia and AV block | Nausea, vomiting, anorexia, weight loss
45
Rivastigmine and Galantamine - Interactions
Both Anticholinergic drugs inhibit effects. Rivastigmine: Nicotine increases oral clearance Galantamine: Inhibitors of CYP2D6 increase serum levels
46
Tacrine - Adverse effects
Hepatotoxicity | Diarrhea, nausea, urinary incontinence
47
Memantine - MoA
Noncompetitive antagonist at NMDA receptor. Blocks glutamate neurotransmission at NMDA receptors.
48
Memantine - Indication
AD | Dementia
49
Memantine - Adverse effects
``` Confusion Dizziness Drowsiness Headache insomnia ```
50
Caprylidene - MoA
Medical food that is metabolized into ketone bodies which the brain can use for energy when the processing of glucose is impaired.
51
Caprylidene - Indication
Age associated memory impairment | AD
52
Dextromethorphan | Quinidine - MoA
Dexmetromethorphan: inhibits excitatory glutamate release by agonist action at sigma-1 receptors and blocks NMDA receptors --> Excitatory neurotransmission that underlies emotion lability is reduced
53
Dextromethorphan | Quinidine - Indication
Emotional lability (pseudobulbar effects). seen in pt w neurodegenerative diseases
54
Dextromethorphan | Quinidine - Interactions
Quinidine is an inhibitor of CYP2D6 and therefore increases the bioavailability of dextromethorphan
55
Drugs for Huntington Disease
Diazepam Haloperidol Tetrabenazine
56
Diazepam - MoA
Potentiate GABA
57
Diazepam - Adverse effects
Arrhytmias, CNS depression, drug dependence, hypotension, and mild respiratory depression
58
Diazepam - Interactions
Alcohol and other CNS depressants potentiate effects. | Cimetidine increases and rifampin decreases serum level
59
Haloperidol - MoA
Block dopamine receptors
60
Haloperidol - Adverse effects
Extrapyramidal side effects | Increased prolactin levels
61
Haloperidol - Interaction
Barbiturates and carbamazepine decrease and quinidine increases serum levels
62
Tetrabenazine - MoA
Reversibly inhibit the human vesicular monoamine transporter type 2 VMAT2, resulting in decreased uptake of monoamine into synaptic vesicles and depletion on monoamine stores (dopamine, norepinephrine, serotonin) leading to decrease neurotransmitter release from nerve terminals.
63
Tetrabenazine - Indication
Chorea in in HD
64
Drugs for Multiple sclerosis
``` Interferon beta-1b Interferon beta-1a Peginterferon beta-1a Natalizumab Daclizumab Alemtuzumab Mitoxantrone Glatiramer acetate Dalfampridine Fingolimod Teriflunomide Dimethyl fumarate Prednisone Baclofen ```
65
Interferon beta-1b - MoA
Increases the cytotoxicity of natural killer cells and increases the phagocytic activity of macrophages. In addition, it reduces the amount of interferon-gamma secreted by activated lymphocytes
66
Interferon beta-1b - Adverse effects and interactions
Chills, diarrhea, fever, headache, hypertension, myalgia, pain and vomiting Increases serum levels of zidovudine
67
Natalizumab - MoA
Block the molecular pathway involving cell adhesion that draws lymphocytes into the CNS
68
Daclizumab - MoA
Monoclonal antibody to IL-2 receptor, block interleukin-mediated activation of lymphocytes
69
Alemtuzumab - MoA
CD52-directed cytolytic monoclonal antibody
70
Alemtuzumab - Adverse effects
Life-threatening adverse effects of autoimmune, infusion reactions, and increased malignancies
71
Mitoxantrone - MoA
Acts by suppressing the activity of T cells, B cells and macrophages that are thought to lead the attack on the myelin sheath. Antineoplastic drug
72
Glatiramer acetate - MoA
Synthetic protein that mimics the structure of the myelin basic protein, a component of the myelin nerve fibers. This drug blocks myelin-damaging T cells by acting as a myelin decoy.
73
Dalfampridine - MoA
Block potassium channels and enhance the conduction in damaged nerves
74
Fingolimod - MoA
Sphingosine-1-phosphate receptor modulator, block the egress of lymphocytes from lymph nodes, reducing the number of lymphocytes in blood.
75
Teriflunomide - MoA
Reduce the proliferation of overactive immune cells (including T- and B-cells) that attack and damage the nerve in the CNS by acting pyrimidine synthesis inhibitor.
76
Teriflunomide- Adverse effects
Hepatotoxicity
77
Dimethyl fumarate - MoA
Its main metabolite is monomethyl fumarate (MMF). MMF activates the Nuclear factor (erythroid-derived 2)-like 2 (Nfr2) pathway.
78
Prednisone - Indication
Acute exacerbations of MS
79
Prednisone - Adverse effects and Interactions
Aggrevation of: DM, GI-bleeding, mood changes, pancreatitis and seizures. Barbiturates, Carbamazepine, phenytoin, rifampin decreases serum levels
80
Which drugs are used for relapsing MS?
``` Interferon beta-1a Alemtuzumab Fingolimod Teriflunomide Dimethyl fumarate ```
81
Drugs for Amyotrophic lateral sclerosis
Baclofen Gabapentin Roluzole
82
Baclofen - MoA + group
GABAb receptor agonist, when activated they reduce motor neuron excitability Antispastic
83
Baclofen - Adverse effects
Dizziness, Fatigue, Weakness
84
Riluzole - MoA
Protect motor neurons from the neurotoxic effects of excitatory amino acids and prevent anoxia-related death of cortical neurons May inhibit voltage-gates sodium channels that mediate the release of glutamate from neurons
85
Riluzole - Indication
ALS Prolongs the time before patients require a tracheotomy and also to prolong life by approximately 3 months. More effective in those with bulbar-onset disease than in those with limb-onset disease
86
Riluzole - Adverse effects and Interactions
Asthenia, diarrhea, dizziness, drowsiness, increased hepatic enzyme levels, nausea, vomiting, paresthesias, vertigo Quinolones and Theophylline increases serum levels. Omeprazole, rifampin and smoking decreases serum levels
87
Antispastic Agents
``` Baclofen Cyclobenzaprine Orphenadrine Methocarbamol Carisoprodol Tizanidine Dantrolene Botulinum Toxin A ```
88
Cyclobenzaprine | Orphenadrine - MoA and Indication
Centrally mediated effects on catecholamine reuptake, and antimuscarinic and antihistaminergic receptor actions Muscle spasms by acute painful musculoskeletal conditions (short-term)-
89
Methocarbamol - MoA
General CNS depression
90
Carisoprodol - Indication
Muscle spasms caused by musculoskeletal conditions (short-term)
91
Tizanidine - MoA and Indication
Centrally acting alpha2 adrenoceptor agonist, blocks nerve impulses through presynaptic inhibition of motor neurons. Spasticity of MS
92
Dantrolene - MoA
Block the release of calcium from the sarcoplasmic reticulum in muscle fibers, directly relaxes the muscle
93
Dantrolene - Indication
Life saving in malignant hyperthermia triggered by halogenated anesthetics Neuroleptic malignant syndrome Spasticity
94
Botulinum toxin A - MoA
Paralyses muscles by blocking the release of acetylcholine on the presynaptic side of the muscle endplate junction
95
Botulinum toxin A - Indication
``` Upper-limb spasticity in stroke patients Cervical dystonia Strabismus Blepharospasm Urinary incontinence resulting from detrusor overactivity in patients with spinal cord injury and MS ```
96
Gabapentin - Group and Indication
Antiepileptic ALS Slows decline in muscle strength
97
Gabapentin - Adverse effects and Interactions
Ataxia, dizziness, drowsiness, nystagmus, tremor Antacids decreases serum levels

Pharmacology (55 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions